These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3226575)

  • 21. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F; Capecchi PL; Acciavatti A; Petri S; de Lalla A; Cati G; Colafati M; Di Perri T
    Clin Hemorheol Microcirc; 1997; 17(1):73-84. PubMed ID: 9181761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(20):867-73. PubMed ID: 3936287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE; Lozinskij LG
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011.
    Bucolo C; Longo L; Camillieri G; Drago F; Salomone S
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1190-6. PubMed ID: 22855302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of long-term safety data with buflomedil.
    Bachand RT; Dubourg AY
    J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of coronary insufficiency with carbochromen].
    Kipsidze NN; Capidze GJ
    Arzneimittelforschung; 1970 Mar; 20():456-9. PubMed ID: 4989253
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myoclonus during a course with buflomedil treatment].
    Lucas C; Soetaert G; Leys D; Petit H
    Acta Clin Belg; 1989; 44(5):360-1. PubMed ID: 2609846
    [No Abstract]   [Full Text] [Related]  

  • 29. Buflomedil: still seizures and cardiac disorders. Too many patients are exposed to an unjustified risk of serious adverse effects.
    Prescrire Int; 2007 Feb; 16(87):15. PubMed ID: 17323522
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of acute and chronic coronary insufficiency with carbochromen].
    Popov VG; Beljakova TI; Sophijeva IJ
    Arzneimittelforschung; 1970 Mar; 20():467-8. PubMed ID: 5468733
    [No Abstract]   [Full Text] [Related]  

  • 31. Anaphylactic reactions to buflomedil.
    Scala E; Guerra EC; Pirrotta L; Giani M; De Pità O; Puddu P
    Allergy; 1999 Mar; 54(3):288-9. PubMed ID: 10321569
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ostium stenosis of the left coronary artery. Diagnostic difficulties and risks of the coronarographic examination. Description of 2 cases].
    Bruzzese P; Angoli L; Specchia G
    Cardiologia; 1982; 27(7):643-50. PubMed ID: 6892443
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trial with Lidoflazine (R-7.904) in coronary insufficiency].
    Maciel LR; do Amarilho IP; Lion MF
    Rev Paul Med; 1970 Sep; 76(7):89-92. PubMed ID: 5511909
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
    Foray J; Baisse PE; Mont JP; Cahen C
    Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute poisoning by buflomedil].
    Medernach C; Garnier R; Efthymiou ML
    Nouv Presse Med; 1981 Nov; 10(42):3496. PubMed ID: 7312610
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency].
    Marignani A; Martelli A; Piana G
    Minerva Cardioangiol; 1973 Sep; 21(9):629-35. PubMed ID: 4745005
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.